Making all clinical trials available for review: any impact on clinical decisions?
Smith
Gary H
GH
School of Pharmacy, University of Maryland, Baltimore, USA. gsmith@rx.umaryland.edu
D022126:Access to Information; D016907:Adverse Drug Reaction Reporting Systems / Q000941:ethics / Q000639:trends; D001294:Attitude to Health; D002986:Clinical Trials as Topic / Q000639:trends*; D003657:Decision Making; D030881:Disclosure; D006801:Humans; D033222:Judicial Role; D007883:Legislation, Medical / Q000941:ethics; D012042:Registries; D012957:Societies, Pharmaceutical / Q000941:ethics; D013219:State Government; D014481:United States; D014486:United States Food and Drug Administration / Q000941:ethics / Q000331:legislation & jurisprudence